期刊文献+

RP-HPLC法测定大鼠血浆中DHX-11的浓度

Determination of content of DHX-11 in rat plasma by RP-HPLC
下载PDF
导出
摘要 目的建立测定大鼠血浆中10-O-[4-(1-乙酰基-5-苯基-4,5-二氢吡唑-3-基)苯基]-(10S)-二氢青蒿素(10-O-[4-[1-acetyl-5-phenyl-4,5-dihydropyrazol-3-yl]phenyl]-(10S)-dihydroartemisinin,DHX-11)的高效液相色谱方法,并应用于DHX-11的药物动力学研究。方法采用反相色谱柱(200mm×4.6 mm,5μm),流动相为甲醇-水(体积比为90∶10),流速为1 mL.min-1,检测波长为294nm,内标为大黄酚,以液液萃取法处理血浆。结果 DHX-11血浆浓度在0.022~1.120 mg.L-1内线性关系良好(r>0.996 0),定量下限为0.022 mg.L-1,日内、日间精密度(以相对标准偏差表示)不大于13.3%,低、中、高质量浓度(0.0448、0.224、0.896 mg.L-1)质控样品回收率分别为92.7%、91.1%、85.7%。大鼠灌胃给药血药浓度-时间数据经DAS2.0药动学软件处理,主要药动学参数为:t1/2:(1.922±0.632)h;CL/F:(104.673±31.629)L.h-.1kg-1;AUC0-t:(3 778.6±1 031.4)μg.h.L-1;AUC0-∞:(3 879.3±1 010.7)μg.h.L-1。结论该方法可作为大鼠血浆中DHX-11浓度的测定方法,为探讨DHX-11的药动学行为提供了方法依据。 Objective To develop an HPLC-UV method for determination of 10-O-[4-[1-acetyl-5-phenyl-4,5-dihydropyrazol-3-yl]phenyl]-(10S)-dihydroartemisinin(DHX-11)in rat plasma.Methods A reverse-phase column(200 mm×4.6 mm,5 μm)was applied with mobile phase consisted of methanol-water(V∶ V=90∶ 10)at a flow rate of 1 mL · min-1,the detection wavelength was set at 294 nm,chrysophanol was used as the internal standard,and the plasma was prepared by liquid-liquid extraction.Results The standard curve was linear over the range of 0.022-1.120 mg · L-1 in rat plasma with correlation coefficient more than 0.996.The lower limit of quantification of the assay was 0.022 mg · L-1.The relative standard deviations of intra-and inter-day assay variations were less than 13.3%.The recoveries of samples at 0.045,0.224 and 0.896 mg · L-1 were 92.7%,91.1% and 85.7% respectively.The plasma concentration-time data after oral administration was calculated by DAS2.1 pharmacokinetic program,and the main pharmacokinetic parameters were:t1/2:(1.922±0.632)h;CL/F:(104.673±31.629)L · h-1 · kg-1;AUC0-t:(3 778.6±1 031.4)μg · h · L-1;AUC0-∞:(3 879.3±1 010.7)μg · h · L-1.Conclusions The method is simple,rapid and accurate and can be applied to investigate the pharmacokinetics of DHX-11 in rats.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2012年第8期615-618,649,共5页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目(81072533) 重大新药创制科技专项项目(2012ZX09103-101-023)
关键词 10-O-[4-(1-乙酰基-5-苯基-4 5-二氢吡唑-3-基)苯基]-(10S)-二氢青蒿素 高效液相色谱 药物动力学 大鼠 10-O-[4-[1-acetyl-5-phenyl-4,5-dihydropyrazol-3-yl]phenyl]-(10S)-dihydroartemisinin(DHX-11); HPLC; pharmacokinetics; rat
  • 相关文献

参考文献9

  • 1郭建红,丘明建.青蒿素类衍生物抗肿瘤研究进展[J].中国现代药物应用,2008,2(1):123-125. 被引量:5
  • 2常明,张相林,刘晓,夏军平,丁庆明.双氢青蒿素人体药动学及生物等效性研究[J].中国药房,2006,17(14):1086-1088. 被引量:4
  • 3赵临襄,杨学林,刘丹,等.青蒿素类衍生物及其应用:中国,CN101580510A[P].2009-11-18.
  • 4严虹霞,张丽锋,张淑秋.青蒿素类抗疟药的药物代谢动力学与药物相互作用[J].中国药物与临床,2006,6(9):645-647. 被引量:9
  • 5WANG Jun-xia, TANG Wei, YANG Zhong-shun, et al. Suppressive effect of a novel water-soluble artemisi- nin derivative SM905 on T cell activation and prolifer- ation in vitro and in vivo [J]. European Journal of Pharmacology ,2007,564.211 - 218.
  • 6BALINT G A. Artemisinin and its derivatives, an im- portant new class of antimalarial agents [ J ]. Pharma- cology & Therapeutics ,2001,90:261 - 265.
  • 7YANG Zbong-shun, WANG Jun-xia, ZHOU Yu, et al. Synthesis and immunosuppressive activity of new arte- misinin derivatives. Part2:2-[12(fl or a)-Dihydroarte- misinoxymethyl-( or l'-ethyl )] phenoxyl propionic acids and esters [J]. Bioorganic & Medicinal Chemis- try,2006,14:8043 - 8049.
  • 8严虹霞.青蒿素类抗疟药代谢动力学研究[D].太原:山西医科大学,2008,8:6-17.
  • 9郑洪伟,牛新文,朱君,王绍杰.查尔酮类化合物生物活性研究进展[J].中国新药杂志,2007,16(18):1445-1449. 被引量:37

二级参考文献91

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部